Description
X-MAB 500 MG is a high-performance monoclonal antibody containing Rituximab, used in the treatment of specific types of blood cancers and autoimmune disorders. Manufactured by RPG Life Sciences, it targets the CD20 antigen on the surface of B-lymphocytes, effectively eliminating these cells to stop cancer progression and reduce severe inflammation. X-Mab is a critical therapy for Non-Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), and severe Rheumatoid Arthritis. It is also indicated for rare autoimmune conditions like Granulomatosis with Polyangiitis (GPA) and Pemphigus Vulgaris.
